Clinical Trial Update: An Immunity Persistence Study of Live Attenuated Varicella Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 immunity persistence study of a live attenuated varicella vaccine is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine (live attenuated) – Sinovac (varicella vaccine live attenuated)

Snippet

Sponsor: Sinovac (Dalian) Vaccine Technology Co., Ltd. | Conditions: Varicella | Phase 4 | Status: ENROLLING_BY_INVITATION